Arkolith/Insider Trading/ARWR/Form 4

Anzalone Christopher Richard

Chief Executive Officer, DirectorARROWHEAD PHARMACEUTICALS, INC. (ARWR) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.4M
Net Open-Market Flow
-$5.4M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Sell(S)36K$64.51$2.3M3.8M
Dec 17, 2025Sell(S)982$65.53$64K3.8M
Dec 17, 2025Sell(S)2K$66.30$131K3.8M
Dec 17, 2025Sell(S)46K$63.55$2.9M3.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001423029-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML